Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

30 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prednisolone-containing liposomes accumulate in human atherosclerotic macrophages upon intravenous administration.
van der Valk FM, van Wijk DF, Lobatto ME, Verberne HJ, Storm G, Willems MC, Legemate DA, Nederveen AJ, Calcagno C, Mani V, Ramachandran S, Paridaans MP, Otten MJ, Dallinga-Thie GM, Fayad ZA, Nieuwdorp M, Schulte DM, Metselaar JM, Mulder WJ, Stroes ES. van der Valk FM, et al. Among authors: van wijk df. Nanomedicine. 2015 Jul;11(5):1039-46. doi: 10.1016/j.nano.2015.02.021. Epub 2015 Mar 17. Nanomedicine. 2015. PMID: 25791806 Free PMC article. Clinical Trial.
Liposomal prednisolone promotes macrophage lipotoxicity in experimental atherosclerosis.
van der Valk FM, Schulte DM, Meiler S, Tang J, Zheng KH, Van den Bossche J, Seijkens T, Laudes M, de Winther M, Lutgens E, Alaarg A, Metselaar JM, Dallinga-Thie GM, Mulder WJ, Stroes ES, Hamers AA. van der Valk FM, et al. Among authors: van den bossche j. Nanomedicine. 2016 Aug;12(6):1463-70. doi: 10.1016/j.nano.2016.02.022. Epub 2016 Mar 23. Nanomedicine. 2016. PMID: 27015770
Novel anti-inflammatory strategies in atherosclerosis.
van der Valk FM, van Wijk DF, Stroes ES. van der Valk FM, et al. Among authors: van wijk df. Curr Opin Lipidol. 2012 Dec;23(6):532-9. doi: 10.1097/MOL.0b013e3283587543. Curr Opin Lipidol. 2012. PMID: 23160400 Review.
A sense of excitement for a specific Lp(a)-lowering therapy.
Stroes ES, van der Valk FM. Stroes ES, et al. Among authors: van der valk fm. Lancet. 2015 Oct 10;386(10002):1427-9. doi: 10.1016/S0140-6736(15)60638-9. Epub 2015 Jul 22. Lancet. 2015. PMID: 26210643 No abstract available.
Current therapies for lowering lipoprotein (a).
van Capelleveen JC, van der Valk FM, Stroes ES. van Capelleveen JC, et al. Among authors: van der valk fm. J Lipid Res. 2016 Sep;57(9):1612-8. doi: 10.1194/jlr.R053066. Epub 2015 Dec 4. J Lipid Res. 2016. PMID: 26637277 Free PMC article. Review.
30 results